STL1, a New AKT Inhibitor, Synergizes with Flavonoid Quercetin in Enhancing Cell Death in A Chronic Lymphocytic Leukemia Cell Line | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

STL1, a New AKT Inhibitor, Synergizes with Flavonoid Quercetin in Enhancing Cell Death in A Chronic Lymphocytic Leukemia Cell Line

Authors:: Carmen Cervellera; Maria Russo; Serena Dotolo; Angelo Facchiano; Gian Luigi Russo

Reference:: Molecules; 2021; 26; 5810

DOI:: 10.3390/molecules26195810

See Abstract

Key Words:: Chronic lymphocytic leukemia; HG3; AKT inhibitor; STL1; quercetin; autophagy; apoptosis

Back to index